Oncology Clinical Trials

For Mercy Research’s oncology team, caring for cancer patients is not just a career—it’s a calling.  We’re honored to help people who are at their most vulnerable.  And we’re inspired by our patients’ courage and resilience.  Mercy Research has hundreds of adult and pediatric cancer specialists who care for almost every kind of cancer.  These nationally known experts engage in clinical research to bring you leading-edge cancer treatments, delivered with the most innovative technologies available.

We’re working to find smarter ways to fight cancer by harnessing the power of genetic testing, gene targeting therapies and activating your body’s immune system to fight cancer. 

Our areas of expertise include:

  • Bladder cancer
  • Blood cancer
  • Breast cancer
  • Colorectal cancer
  • Head and neck cancer
  • Lung cancer
  • Prostate cancer and other genitourinary cancers
  • Sarcomas
  • Skin cancer

Cancer Research for the Ozarks

Cancer Research for the Ozarks’ designation as a National Cancer Institute (NCI) Community Oncology Research Program (NCORP) provides Mercy with access to federally funded clinical trials. Cancer Research for the Ozarks (Ozarks NCORP) was established in the spirit of collaboration between the health systems of Mercy and CoxHealth in Springfield, MO, providing innovative cancer research, education, and personal, compassionate presence with patients, family members and staff.

The overall goal of an NCORP is to bring cancer clinical trials and cancer care delivery research (CCDR) to individuals in their own communities, where the majority of cancer patients receive their treatment.

Cancer Research for the Ozarks has integrated CCDR – a multispecialty science – into its core and component sites offering researchers the ability to collect primary data, initiate interventions and follow patients from time of diagnosis through treatment and survivorship.

Participating in CCDR provides opportunities to expand our understanding of how care is delivered in the community. The studies are designed to improve clinical outcomes and patient well-being, enhance patient experiences and optimize value by intervening on patient, clinician and organizational factors that influence the continuum of care delivery utilizing evidence-based practice change. For this reason, CCDR trials are often focused on practice site processes as well as patient-participants.

CCDR is an integrated component of the National Cancer Institute. Research in the community setting allows access to a larger and more diverse patient population in a variety of real-world health care locations. Cancer Research for the Ozarks is proud to be a part of the NCI and participate in this important area of research.

Guardian Research Network 

Mercy Research is a founding partner of Guardian Research Network (GRN), a consortium of like-minded health systems engaged in oncology research. GRN’s objectives are to accelerate cures for cancer, bring clinical trials to community health settings and eliminate the difficulties of matching patients to clinical trials. To know more about GRN’s support to oncology research, click here.